Financhill
Sell
48

GNRC Quote, Financials, Valuation and Earnings

Last price:
$131.53
Seasonality move :
1.55%
Day range:
$130.07 - $132.22
52-week range:
$115.76 - $195.94
Dividend yield:
0%
P/E ratio:
24.36x
P/S ratio:
1.85x
P/B ratio:
3.14x
Volume:
1.1M
Avg. volume:
931.5K
1-year change:
9.66%
Market cap:
$7.8B
Revenue:
$4.3B
EPS (TTM):
$5.40

Earnings Data

Next earnings date for GNRC
May 01
2025
Most recent earnings per share
$2.15
Missed by $0.38
(Feb 12/2025)
Consensus Estimate
$2.53
(Feb 12/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

GNRC Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/01/2025 Q1 $921.5M -- -- $0.97 --
02/12/2025 Q4 $1.2B $1.2B $2.15 $2.53 -$0.38
10/31/2024 Q3 $1.2B $1.2B $1.89 $1.95 -$0.06
07/31/2024 Q2 $1B $998.2M $0.97 $1.20 -$0.23
05/01/2024 Q1 $892.7M $889.3M $0.39 $0.71 -$0.32
02/14/2024 Q4 $1.1B $1.1B $1.57 $2.09 -$0.52
11/01/2023 Q3 -- -- $0.97 $1.51 -$0.54
08/02/2023 Q2 -- -- $0.70 $1.18 -$0.48
05/03/2023 Q1 -- -- $0.05 $0.50 -$0.45
02/15/2023 Q4 -- -- $0.83 $1.75 -$0.92
11/02/2022 Q3 -- -- $0.83 $1.82 -$0.99
08/03/2022 Q2 -- -- $2.21 $2.64 -$0.43
05/04/2022 Q1 -- -- $1.57 $1.92 -$0.35
02/16/2022 Q4 -- -- $2.04 $2.40 -$0.36
11/02/2021 Q3 -- -- $1.93 $2.39 -$0.46
07/28/2021 Q2 -- -- $2.01 $2.32 -$0.31
04/29/2021 Q1 -- -- $2.33 $1.88 $0.45
02/11/2021 Q4 -- -- $1.97 $1.96 $0.01
10/28/2020 Q3 -- -- $1.82 $1.71 $0.11
07/30/2020 Q2 -- -- $1.02 $0.89 $0.13
04/30/2020 Q1 -- -- $0.68 $0.80 -$0.12
02/13/2020 Q4 -- -- $1.12 $1.37 -$0.25
10/31/2019 Q3 -- -- $1.18 $1.33 -$0.15
08/01/2019 Q2 -- -- $1.20 $1.09 $0.12
05/02/2019 Q1 -- -- $0.91 $0.78 $0.14
02/14/2019 Q4 -- -- $1.42 $1.39 $0.03
11/01/2018 Q3 -- -- $1.43 $1.08 $0.35
08/01/2018 Q2 -- -- $1.11 $0.90 $0.21
05/02/2018 Q1 -- -- $0.74 $0.63 $0.11
02/13/2018 Q4 -- -- $1.37 $1.20 $0.18
11/01/2017 Q3 -- -- $0.93 $0.88 $0.05
08/02/2017 Q2 -- -- $0.69 $0.64 $0.05
04/27/2017 Q1 -- -- $0.41 $0.41 $0.00
02/14/2017 Q4 -- -- $1.12 $1.03 $0.09
10/26/2016 Q3 -- -- $0.82 $0.76 $0.06
08/02/2016 Q2 -- -- $0.64 $0.59 $0.05
05/04/2016 Q1 -- -- $0.46 $0.42 $0.04
02/16/2016 Q4 -- -- $0.97 $0.88 $0.09
10/28/2015 Q3 -- -- $0.92 $0.81 $0.11
08/06/2015 Q2 -- -- $0.50 $0.60 -$0.10
04/30/2015 Q1 -- -- $0.49 $0.64 -$0.15

Generac Holdings Earnings Questions

  • How Much did Generac Holdings Generate in Revenue Last Quarter?

    Generac Holdings reported $1.2B worth of top line sales in its most recent quarter.

  • Did Generac Holdings Beat Earnings Last Quarter?

    Generac Holdings announced earnings per share of $2.15 which represents a miss of analyst forecast a $2.53 per share.

  • Is Generac Holdings Profitable?

    Generac Holdings reported $501.4M that represents $8.36 per share over the last quarter.

  • What is the Analyst Consensus for Generac Holdings EPS Next Year?

    Generac Holdings's earnings are forecast to grow from $5.39 per share to $7.80 per share next year representing an increase of 44.68%.

  • When is Generac Holdings's Earnings Date?

    Generac Holdings's next earnings date is May 1, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is CyberArk Stock a Buy, Sell or Hold?
Is CyberArk Stock a Buy, Sell or Hold?

CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…

Is Amazon Stock Still Worth Staking On?
Is Amazon Stock Still Worth Staking On?

Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…

Is Palantir a Good Stock to Buy?
Is Palantir a Good Stock to Buy?

Palantir Technologies (PLTR) stock soared to its highest level in…

Stock Ideas

Buy
55
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Sell
50
RGC alert for Mar 22

Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.

Sell
36
VMI alert for Mar 22

Valmont Industries [VMI] is down 12.54% over the past day.

Buy
61
ALNY alert for Mar 22

Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock